Mounjaro 12.5mg/0.5ml is a higher intermediate dose used in the treatment of type 2 diabetes for improved blood sugar control. It contains tirzepatide, which activates GIP and GLP-1 receptors to regulate glucose levels and support weight management. This dose is often prescribed as patients advance in therapy. Each pack includes a single pre-filled pen for weekly subcutaneous injection. Use under medical supervision only.